UW Medicine will be part of the Cellular Senescence Network to research these cells in aging and other processes.
These National Institutes of Health grants will support trailblazing ideas for solving critical questions in biomedical science.
A laboratory breakthrough in cell targeting may improve the safety of cancer-killing CAR T cells.
Veana and UW Medicine are evaluating a combination of alpha-TEA and trastuzumab for advanced HER2 positive breast cancer
Results challenge the view that immunotherapies are unlikely to be effective against this deadly cancer, the researchers say.
Survival rates seen today among patients with advanced Merkel cell carcinoma were unheard-of with chemotherapy.
UW Medicine and Fred Hutch had key roles in clinical trial of immunotherapy option for often-lethal Merkel cell cancer.
Frisco, Texas, resident Steve Murphy, 66, was diagnosed last September with Merkel cell carcinoma, a rare skin cancer he’d never heard of. His grim prognosis: 50 percent chance of surviving 90 days.
Aging baby boomers are anticipated to propel cases of Merkel cell carcinoma, an often-fatal disease.
One in eight women in the United States is diagnosed with breast cancer. For women who survive, there’s always concern about the cancer coming back. Scientists at UW Medicine in Seattle are developing a new vaccine to try to stop such recurrenc